Skip to main content

Find Clinical Trials

Home
Conditions
IgA Monoclonal Gammopathy of Undetermined Significance

Clinical trial condition

IgA Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying IgA Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

IgA Monoclonal Gammopathy of Undetermined Significance trial results

Recruiting

Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined Significance

NCT07209371

Conditions: IgA Monoclonal Gammopathy of Undetermined Significance, Non-IgM Monoclonal Gammopathy of Undetermined Significance
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Non-IgM Monoclonal Gammopathy of Undetermined Significance (1)